Anuh Pharma shines on receiving CEP for Ambroxol Hydrochloride

20 Feb 2020 Evaluate

Anuh Pharma is currently trading at Rs. 149.90, up by 7.20 points or 5.05% from its previous closing of Rs. 142.70 on the BSE.

The scrip opened at Rs. 142.25 and has touched a high and low of Rs. 158.80 and Rs. 140.45 respectively. So far 2941 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 169.60 on 06-Feb-2020 and a 52 week low of Rs. 101.25 on 02-Aug-2019.

Last one week high and low of the scrip stood at Rs. 158.80 and Rs. 133.10 respectively. The current market cap of the company is Rs. 357.05 crore.

The promoters holding in the company stood at 72.03%, while Institutions and Non-Institutions held 0.01% and 27.95% respectively.

Anuh Pharma has received Certificate of Suitability of European Pharmacopeia (CEP) for Ambroxol Hydrochloride (HCL) for Supply to European Union (EU) Market.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Share Price

82.55 3.39 (4.28%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×